Back to Trades
Other4
Spyre Therapeutics, Inc.
SYRE
Total Value
$16.2M
Company Information
- Company Name
- Spyre Therapeutics, Inc.
- Ticker Symbol
- SYRE
- CIK
- 0001636282
Insider Information
- Name
- Turtle Cameron
- Role
- Chief Executive Officer, Director
- Location
- WALTHAM, MA
Filing Details
- Filing Date
- Jan 13, 2026
- Transaction Date
- Jan 9, 2026
- Accession Number
- 0001636282-26-000003
- Form Type
- 4